Pancreatic Cancer News and Research

RSS
Pancreatic cancer is the fourth leading cause of all cancer deaths in the United States and the third leading cause of cancer deaths in individuals ages 40 to 60. Approximately 37,000 Americans are diagnosed with pancreatic cancer each year, and, each year, approximately the same number die from it. Often, pancreatic cancer is found too late for surgical intervention, and chemotherapy and radiation treatments have little effect.
Blood test may aid in early detection of pancreatic cancer

Blood test may aid in early detection of pancreatic cancer

Blood test may help doctors catch pancreatic cancer early

Blood test may help doctors catch pancreatic cancer early

Aspirin associated with reduction in risk of several digestive tract cancers

Aspirin associated with reduction in risk of several digestive tract cancers

Experimental drug could stop tumor relapse, mice study shows

Experimental drug could stop tumor relapse, mice study shows

Technologies converge on interacting surfaces in protein complexes

Technologies converge on interacting surfaces in protein complexes

New insights into the building blocks of periodontitis

New insights into the building blocks of periodontitis

The building blocks of gum disease

The building blocks of gum disease

Active support for stem cell research is key to alleviate incurable chronic diseases

Active support for stem cell research is key to alleviate incurable chronic diseases

Starving pancreatic cancer cells of cysteine may induce tumor ferroptosis

Starving pancreatic cancer cells of cysteine may induce tumor ferroptosis

New blood test detects more than 50 types of cancer, including at early, more treatable stages

New blood test detects more than 50 types of cancer, including at early, more treatable stages

New blood test accurately detects more than 50 types of cancer

New blood test accurately detects more than 50 types of cancer

Overview of prognostic and predictive factors in pancreatic cancer

Overview of prognostic and predictive factors in pancreatic cancer

A miRNA signature linked to local-regional failure and overall survival after pancreatic cancer resection

A miRNA signature linked to local-regional failure and overall survival after pancreatic cancer resection

MicroRNA dysregulation has critical impacts on development, inflammation and cancer development

MicroRNA dysregulation has critical impacts on development, inflammation and cancer development

Characterization of DNAm status of MMPs and TIMPs in atheromatous plaques

Characterization of DNAm status of MMPs and TIMPs in atheromatous plaques

Microbial DNA in the blood could help identify who has cancer

Microbial DNA in the blood could help identify who has cancer

Research introduces a new concept of resectability in pancreatic cancer

Research introduces a new concept of resectability in pancreatic cancer

Combination of anti-cancer nanodrugs with Intralipid enhances therapeutic efficacy

Combination of anti-cancer nanodrugs with Intralipid enhances therapeutic efficacy

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

The Pancreatic Cancer Collective awards additional funding of $16 million for new therapies

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

New type of adoptive cell therapy could target prostate and pancreatic cancers in humans

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.